Atrial fibrillation Reducing The Risk of Stroke Bjrn Fredriksson - PowerPoint PPT Presentation

Atrial fibrillation Reducing The Risk of Stroke Björn Fredriksson Arrhythmia Process Cardiologist Department of Medicine International forum on quality and safety in healthcare Södra Älvsborgs Sjukhus

Atrial fibrillation 30% of all stroke – associated with atrial fibrillation. Causes worse functional incapacity and have a higher mortality – compared to other strokes. Anticoagulants leads to 65% reduction in stroke Södra Älvsborgs Sjukhus

Challenges • Few patients were treated with anticoagulants. • Patients with atrial fibrillations are everywhere – not only in the cardiology department. • Doctors have different opinions about who should get anticoagulants. Södra Älvsborgs Sjukhus

What is the Standard care formula Patient information patients need? Updating: Heart handbook What have we Administrative Medial hype support done? Check lists, Mequal, Teaching Simple referring • Patients Measurements – • Nurses what is important? Out patient • Doctors department Södra Älvsborgs Sjukhus

Interviews with patients Patient information can be improved Unclear where to contact regarding problems with atrial fibrillation Södra Älvsborgs Sjukhus

Heart Hand Book Simple message: Count the riskscore for stroke: Treat if score is 1 or above Standard care list Södra Älvsborgs Sjukhus

Patient information One of the most important things we have done. Södra Älvsborgs Sjukhus

Outpatients with atrial fibrillation. 2015: 81% treated with anticoagulants Södra Älvsborgs Sjukhus

Patients in ward departments with atrial fibrillation: 2015: 76% treated with anticoagulants. Södra Älvsborgs Sjukhus

Atrial fibrillation Reducing The Risk of Stroke Bjrn Fredriksson - PowerPoint PPT Presentation

Atrial fibrillation Reducing The Risk of Stroke Bjrn Fredriksson Arrhythmia Process Cardiologist Department of Medicine International forum on quality and safety in healthcare Sdra lvsborgs Sjukhus Atrial fibrillation 30% of all

Management of Atrial Fibrillation Management of Atrial Fibrillation Nitish Badhwar, MD, FACC

Update on atrial fibrillation management Disclosure Catheter Ablation of Atrial Fibrillation:

Stroke Awareness Seminar Liz Barber, Stroke Service Development Sister Stroke Awareness seminar

Risk Scores for Stroke Risk and Bleeding in Atrial Fibrillation: Accuracy and Utility in Trials

RACE 3 Risk Factor Driven Upstream Therapy in Early Persistent Atrial Fibrillation The Routine

RACE 3 Risk Factor Driven Upstream Therapy in Early Persistent Atrial Fibrillation The Routine

Appendage Closure Versus Warfarin for Stroke Prevention in Atrial Fibrillation Vivek Y Reddy 1 ,

Management and one year outcome of atrial fibrillation in Middle Eastern cohort enrolled in the

KPAF trial The Kansai Plus Atrial Fibrillation (KPAF) trial is a 2x2 factorial randomized

Atrial Fibrillation (AFib): What You Need to Know 2018 Acknowledgements Thank you to

Defining Sub-Clinical Atrial Fibrillation and its management Jeff Healey MD, MSc, FRCP, FHRS

Atrial Fibrillation Saeed Oraii MD, Cardiologist Interventional Electrophysiologist Tehran

Atrial Appendage Occlusion Among Patients with Atrial Fibrillation Undergoing Concomitant Cardiac

Case 2: Reducing Cardiovascular Risk Type 2 Diabetes Management Case 1: Reducing Hypoglycemic

Improving Stroke Prevention in Patients With Atrial Fibrillation Acknowledgement Disclosures

Updating Systematic Reviews: Stroke Prevention in Atrial Fibrillation A PCORI Virtual

EXPANDED MANDATE: MEDICINES PATENT POOL FOR ESSENTIAL MEDICINES KEY FINDINGS OF THE FEASIBILITY

Drug Spending % of Healthcare Spending DRUG SPENDING % OF HEALTHCARE SPENDING 20% 15% Japan,

Showcasing health innovation Dr Samus ONeill Chair AHSN Network, CEO AHSN North East and

Updates in Thrombosis Dr. Ali Y. Al-Muhaini MBBch FRCP(C) Chairman of the Internal Medicine

Sandy Bartlett, PhD, PharmD, BCPS Associate Professor | Department of Pharmacy Practice Conflict

Updates from the Pharmacovigilance and Special Access Branch Dr Grant Pegg Director, Signal

Effectiveness and safety of direct oral anticoagulants versus VKA a cohort study of about 100,000

Emergency Treatment of Ischemic Stroke JEFFREY BOYLE, M.D., PHD CLINICAL DIRECTOR OF STROKE AT

Explore More Topics

Sambuz

Useful Links

Newsletter

Mail Us